×
Veracyte EBIT 2012-2025 | VCYT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Veracyte ebit from 2012 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Veracyte EBIT 2012-2025 | VCYT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Veracyte ebit from 2012 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$185B
Thermo Fisher Scientific (TMO)
$152.9B
Edwards Lifesciences (EW)
$44.9B
Alcon (ALC)
$43B
IDEXX Laboratories (IDXX)
$41.9B
DexCom (DXCM)
$32.9B
IQVIA Holdings (IQV)
$27.5B
Mettler-Toledo (MTD)
$24.2B
STERIS (STE)
$21.9B
SONOVA HOLDING (SONVY)
$17.2B
Waters (WAT)
$16.8B
Hologic (HOLX)
$14.2B
Sysmex ADR (SSMXY)
$10.5B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.4B
Globus Medical (GMED)
$7B
Glaukos (GKOS)
$5.5B
Teleflex (TFX)
$4.9B
Integer Holdings (ITGR)
$3.9B
TransMedics (TMDX)
$3.5B
PROCEPT BioRobotics (PRCT)
$3.2B
LivaNova (LIVN)
$2.3B
Nihon Kohden (NHNKY)
$2.2B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.5B
Artivion (AORT)
$1.3B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B
Pulse Biosciences (PLSE)
$1B
Tandem Diabetes Care (TNDM)
$974M